Amylyx Pharmaceuticals
The Associate Director, Regulatory CMC at Amylyx Pharmaceuticals leads regulatory strategy and operations for CMC activities to advance the company’s clinical-stage product portfolio. This role coordinates with internal teams and external partners to ensure products meet global regulatory requirements and supports regulatory interactions and submissions across major health authorities. The position supports program advancement across early and late-stage development while enabling cross-functional alignment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Senior Director, CMC Regulatory
Kardigan
Senior Director, CMC Regulatory
Kardigan
Director, Global Regulatory Affairs (GRA) - CMC
Ironwood Pharmaceuticals
Global Regulatory Affairs CMC Lead
City of Pierre, South Dakota
Associate Director, Regulatory CMC (Small Molecule)
BeOne Medicines
Director, Regulatory CMC
Acadia Pharmaceuticals Inc.